GPR55 and colitis: Although it exerts anti-inflammatory effects on both DSS and TNBS colitis, this is independent of GPR55 as genetic knockout of this receptor, and indeed of both CB1 and CB2, does not alter the effect of O-1602.100 It is not known therefore by which pathways this compound acts on in colitis.